Retool Your 60/40 Portfolio for Income, Says BlackRock
August 29, 2024: In today’s evolving investment landscape, the traditional 60/40 portfolio, consisting of 60% stocks and 40% bonds, may require a strategic overhaul
Goldman Sachs: Two Major Investor Groups Favor These Stocks
August 24, 2024: Goldman Sachs has recently identified a group of stocks that have garnered significant interest from two major investor groups.
Wolfe Research: Financials Offer ‘Stealth Bull Market’ Opportunity
August 28, 2024: Wolfe Research has identified the financial sector as a potential “stealth bull market,” suggesting that this often-overlooked asset class
FDA Approves Updated Pfizer, Moderna Vaccines Amid Covid Surge
August 23, 2024: In a timely response to the rising number of COVID-19 cases, the Food and Drug Administration (FDA) has granted emergency use authorization (EUA)vaccines.
T.J. Maxx Owner Lifts Full-Year Outlook with 5.6% Sales Growth
August 21, 2024: TJX Companies, Inc., the parent company of popular retailers such as T.J. Maxx and Marshalls, has reported a strong financial performance for its most recent quarter,
Utilities Sector Bullish, Industry Leader Breaking Out
August 21, 2024: Market analysts are growing optimistic about the utility sector, with recent chart patterns suggesting a potential uptrend. One particular industry member has emerged as a standout,
The Business Show LA 2024!
August 20, 2024: The world’s largest business show returns to LA in 2024. It is taking place on the 9th & 10th of October 2024 at The LA Convention Center and running alongside The B2B Marketing Expo.
D1 Capital Reshapes Portfolio: Exits Meta and Alphabet
August 15, 2024: D1 Capital, the prominent hedge fund founded by Daniel Sundheim, has undergone a significant portfolio restructuring.
Strategas Recommends Quality Stocks to Buy Amid Pullback
August 14, 2024: Amidst market volatility and potential pullback, investment research firm Strategas has curated a list of high-quality stocks deemed worthy of investor consideration.
Eli Lilly Raises Guidance as Zepbound, Mounjaro Sales Soar
August 13, 2024: Pharmaceutical giant Eli Lilly and Company has reported financial results that surpassed analyst estimates for the second quarter of the fiscal year.
